Back to Results
First PageMeta Content
Polycythemia vera / Essential thrombocytosis / Fibrosis / Medicine / Myeloproliferative disease / Myelofibrosis


Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre
Add to Reading List

Document Date: 2014-06-13 01:07:42

Open Document

File Size: 1,74 MB

Share Result on Facebook
UPDATE